Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes.
暂无分享,去创建一个
Kevin Grove | Matthias von Herrath | Philippe P Pagni | Gustaf Christoffersson | Mads Tang-Christensen | Allan Ertmann Karlsen | Jacob Sten Petersen | J. Petersen | M. V. von Herrath | K. Grove | M. Tang-Christensen | G. Christoffersson | Philippe P. Pagni | A. Karlsen
[1] D. Melton,et al. Resolving Discrepant Findings on ANGPTL8 in β-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy , 2016, PloS one.
[2] C. Begley,et al. Drug development: Raise standards for preclinical cancer research , 2012, Nature.
[3] D. Cohen,et al. Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. , 1997, The Journal of clinical investigation.
[4] L. B. Knudsen,et al. The glucagon-like peptide-1 receptor--or not? , 2013, Endocrinology.
[5] K. Kaestner,et al. GABA and Artesunate Do Not Induce Pancreatic α-to-β Cell Transdifferentiation In Vivo. , 2018, Cell metabolism.
[6] R. Bronson,et al. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope , 2011, The Journal of experimental medicine.
[7] Casper Bo Jensen,et al. Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization , 2018, Endocrinology.
[8] B. Hummer,et al. Pancreatic safety of incretin-based drugs--FDA and EMA assessment. , 2014, The New England journal of medicine.
[9] A. Ericsson,et al. Microbiota and reproducibility of rodent models , 2017, Lab Animal.
[10] O. Madsen,et al. Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis , 2017, Cell.
[11] M. Atkinson,et al. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice , 2015, Diabetes.
[12] M. Lenardo,et al. Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice , 2017, Diabetologia.
[13] A. Talebi,et al. GABA dramatically improves glucose tolerance in streptozotocin‐induced diabetic rats fed with high‐fat diet , 2018, European journal of pharmacology.
[14] O. Kuda. On the Complexity of PAHSA Research. , 2018, Cell metabolism.
[15] Brian A. Nosek,et al. Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.
[16] A. Saghatelian,et al. Methodological Issues in Studying PAHSA Biology: Masking PAHSA Effects. , 2018, Cell metabolism.
[17] K. Herold,et al. Thinking bedside at the bench: the NOD mouse model of T1DM , 2015, Nature Reviews Endocrinology.
[18] P. Butler,et al. Glucagon like peptide-1 receptor expression in the human thyroid gland. , 2012, The Journal of clinical endocrinology and metabolism.
[19] H. Garren,et al. Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice , 2013, PloS one.
[20] M. Krashes,et al. Asprosin is a centrally-acting orexigenic hormone , 2017, Nature Medicine.
[21] C. Wollheim,et al. GABA in the Endocrine Pancreas , 2004, The Journal of general physiology.
[22] S. Helene Richter,et al. Environmental standardization: cure or cause of poor reproducibility in animal experiments? , 2009, Nature Methods.
[23] U. Schwahn,et al. Acute and Repeated Treatment with 5-PAHSA or 9-PAHSA Isomers Does Not Improve Glucose Control in Mice. , 2018, Cell metabolism.
[24] D. Drucker,et al. Never Waste a Good Crisis: Confronting Reproducibility in Translational Research. , 2016, Cell metabolism.
[25] Christoph Bock,et al. Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity , 2017, Cell.
[26] F. Prinz,et al. Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.
[27] John P. A. Ioannidis,et al. A manifesto for reproducible science , 2017, Nature Human Behaviour.
[28] D. Gary Gilliland,et al. Drug development and clinical trials—the path to an approved cancer drug , 2012, Nature Reviews Clinical Oncology.
[29] Sirong He,et al. Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice. , 2016, Molecular immunology.
[30] S. Dry,et al. Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model , 2012, Diabetes.
[31] Mark S. Anderson,et al. The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.
[32] Yiming Li,et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes , 2011, Proceedings of the National Academy of Sciences.
[33] L. Bardram,et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. , 2014, Endocrinology.
[34] A. Ponery,et al. GABA in the endocrine pancreas: cellular localization and function in normal and diabetic rats. , 2002, Tissue & cell.
[35] C. Donaldson,et al. Artemether Does Not Turn α Cells into β Cells. , 2018, Cell metabolism.
[36] H. Garren,et al. Improved Efficacy of a Tolerizing DNA Vaccine for Reversal of Hyperglycemia through Enhancement of Gene Expression and Localization to Intracellular Sites , 2008, The Journal of Immunology.
[37] J. Ioannidis. Why Most Published Research Findings Are False , 2019, CHANCE.
[38] A. Gore. Editorial: antibody validation requirements for articles published in endocrinology. , 2013, Endocrinology.
[39] Christian Skonberg,et al. Oral insulin (human, murine, or porcine) does not prevent diabetes in the non-obese diabetic mouse. , 2016, Clinical immunology.
[40] Jonathan C. Cohen,et al. ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion , 2014, Cell.
[41] Thiago Lopes-Carvalho,et al. Tolerogenic insulin peptide therapy precipitates type 1 diabetes , 2017, The Journal of experimental medicine.
[42] D. Melton,et al. RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation , 2013, Cell.
[43] J. Flier,et al. Irreproducibility of published bioscience research: Diagnosis, pathogenesis and therapy , 2016, Molecular metabolism.
[44] M. Baker. 1,500 scientists lift the lid on reproducibility , 2016, Nature.
[45] J. Ioannidis,et al. Reproducibility in Science: Improving the Standard for Basic and Preclinical Research , 2015, Circulation research.
[46] I. Cuthill,et al. Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .
[47] D. Drucker. Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls , 2013, Diabetes.